Alembic Pharmaceuticals said it has received a final inspection report from the USFDA for its Panelav manufacturing plants, confirming closure of the May review with no outstanding compliance issues.
Alembic Pharmaceuticals said it has received a final inspection report from the USFDA for its Panelav manufacturing plants, confirming closure of the May review with no outstanding compliance issues.